Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2007 3
2008 2
2009 1
2010 1
2016 1
2017 1
2018 1
2019 6
2020 6
2021 5
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alexey shulga (2 results)?
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors.
Larkina M, Varvashenya R, Yuldasheva F, Plotnikov E, Bezverkhniaia E, Tretyakova M, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Belousov M, Orlova A, Tolmachev V, Deyev S. Larkina M, et al. Among authors: schulga a. Mol Pharm. 2024 Apr 1;21(4):1919-1932. doi: 10.1021/acs.molpharmaceut.3c01173. Mol Pharm. 2024. PMID: 38557163
Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy.
Tolmachev V, Bodenko V, Oroujeni M, Deyev S, Konovalova E, Schulga A, Lindbo S, Hober S, Bragina O, Orlova A, Vorobyeva A. Tolmachev V, et al. Among authors: schulga a. Int J Mol Sci. 2022 Dec 2;23(23):15181. doi: 10.3390/ijms232315181. Int J Mol Sci. 2022. PMID: 36499504 Free PMC article.
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer.
Larkina M, Plotnikov E, Bezverkhniaia E, Shabanova Y, Tretyakova M, Yuldasheva F, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Garousi J, Gräslund T, Belousov M, Tolmachev V, Deyev S. Larkina M, et al. Among authors: schulga a. Int J Mol Sci. 2022 Nov 3;23(21):13443. doi: 10.3390/ijms232113443. Int J Mol Sci. 2022. PMID: 36362226 Free PMC article.
Switchable targeting of solid tumors by BsCAR T cells.
Stepanov AV, Kalinin RS, Shipunova VO, Zhang D, Xie J, Rubtsov YP, Ukrainskaya VM, Schulga A, Konovalova EV, Volkov DV, Yaroshevich IA, Moysenovich AM, Belogurov AA Jr, Zhang H, Telegin GB, Chernov AS, Maschan MA, Terekhov SS, Wu P, Deyev SM, Lerner RA, Gabibov AG, Altman S. Stepanov AV, et al. Among authors: schulga a. Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2210562119. doi: 10.1073/pnas.2210562119. Epub 2022 Nov 7. Proc Natl Acad Sci U S A. 2022. PMID: 36343224 Free PMC article.
Effect of Surface Modification of Multifunctional Nanocomposite Drug Delivery Carriers with DARPin on Their Biodistribution In Vitro and In Vivo.
Novoselova M, Chernyshev VS, Schulga A, Konovalova EV, Chuprov-Netochin RN, Abakumova TO, German S, Shipunova VO, Mokrousov MD, Prikhozhdenko E, Bratashov DN, Nozdriukhin DV, Bogorodskiy A, Grishin O, Kosolobov SS, Khlebtsov BN, Inozemtseva O, Zatsepin TS, Deyev SM, Gorin DA. Novoselova M, et al. Among authors: schulga a. ACS Appl Bio Mater. 2022 Jun 20;5(6):2976-2989. doi: 10.1021/acsabm.2c00289. Epub 2022 May 26. ACS Appl Bio Mater. 2022. PMID: 35616387
41 results